David Katz
Matrix Advisors Value Fund
David Katz Gilead Sciences Inc stake
total: 54
Matrix Advisors Value Fund GILD trades
- Total transactions:
- 15
- New positions:
- 1
- Sold out:
- 1
- Added:
- 7
- Reduced:
- 6
- Held since:
- 2020 Q1
- Held for:
- 17 quarters
- Latest activity:
- 2024 Q2
According to 2024 Q4 report, David Katz doesn't hold any Gilead Sciences Inc (GILD) shares. To date, the estimated cost basis is nearly $74.08 for "buy" trades and estimated average "sell" price is $68.69. Matrix Advisors Value Fund first purchased GILD in 2020 Q1, initially acquiring 25,175 shares. Since the initial investment in Gilead Sciences Inc (GILD), Matrix Advisors Value Fund has made 14 more transactions.
When did David Katz sell Gilead Sciences Inc (GILD)?
David Katz sold off the entire Gilead Sciences Inc (GILD) position in 2024 Q2.
When did David Katz buy Gilead Sciences Inc (GILD)?
David Katz first invested in Gilead Sciences Inc (GILD) in 2020 Q1 at the reported quarter-end price of $74.76 per share.
What's the cost basis of Matrix Advisors Value Fund's GILD stake?
The estimated cost basis for Gilead Sciences Inc (GILD) stake is around $74.08 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $74.08
- Weighted AVG sell price:
- $68.69
David Katz's historical trades in Gilead Sciences Inc
15 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q2
|
0.00%
|
0
|
$73.25
|
|
-100% (-17,600)
|
-1.99%
|
|
2024 Q1
|
1.99%
|
17,600
|
$73.25
|
$1,289,200
|
+12.82% (+2,000)
|
+0.23%
|
|
2023 Q4
|
2.09%
|
15,600
|
$81.01
|
$1,263,756
|
-16.13% (-3,000)
|
-0.45%
|
|
2023 Q3
|
2.60%
|
18,600
|
$74.94
|
$1,393,884
|
+20.39% (+3,150)
|
+0.44%
|
|
2023 Q2
|
2.09%
|
15,450
|
$77.07
|
$1,190,732
|
+4.39% (+650)
|
+0.09%
|
|
2023 Q1
|
2.24%
|
14,800
|
$82.97
|
$1,227,956
|
+146.67% (+8,800)
|
+1.33%
|
|
2022 Q3
|
0.76%
|
6,000
|
$61.69
|
$370,140
|
-42.31% (-4,400)
|
-0.51%
|
|
2022 Q2
|
1.21%
|
10,400
|
$61.81
|
$642,824
|
-63.38% (-18,000)
|
-1.69%
|
|
2021 Q4
|
2.93%
|
28,400
|
$72.61
|
$2,062,124
|
-9.98% (-3,150)
|
-0.34%
|
|
2021 Q3
|
3.28%
|
31,550
|
$69.85
|
$2,203,768
|
-1.41% (-450)
|
-0.05%
|
|
2021 Q1
|
3.42%
|
$64.63
|
+32.78% (+7,900)
|
|||
|
2020 Q4
|
2.61%
|
$58.26
|
+2.55% (+600)
|
|||
|
2020 Q3
|
3.14%
|
$63.19
|
+5.86% (+1,300)
|
|||
|
2020 Q2
|
3.55%
|
$76.94
|
-11.82% (-2,975)
|
|||
|
2020 Q1
|
4.76%
|
$74.76
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.